Similar articles for PMID: 20166099

Year	Number of Results
1986	2
2002	2
2003	5
2004	4
2005	2
2006	4
2007	1
2008	1
2009	2
2010	5
2011	7
2012	9
2013	14
2014	7
2015	3
2016	5
2017	3
2018	9
2019	13
2020	10
2021	13
2022	9
2023	2
2024	1

1

Momordica charantia for type 2 diabetes mellitus.

Ooi CP, Yassin Z, Hamid TA. Ooi CP, et al. Cochrane Database Syst Rev. 2010 Feb 17;(2):CD007845. doi: 10.1002/14651858.CD007845.pub2. Cochrane Database Syst Rev. 2010. PMID: 20166099 Updated. Review.

2

Momordica charantia for type 2 diabetes mellitus.

Ooi CP, Yassin Z, Hamid TA. Ooi CP, et al. Cochrane Database Syst Rev. 2012 Aug 15;(8):CD007845. doi: 10.1002/14651858.CD007845.pub3. Cochrane Database Syst Rev. 2012. PMID: 22895968 Free article. Review.

3

Momordica charantia L. lowers elevated glycaemia in type 2 diabetes mellitus patients: Systematic review and meta-analysis.

Peter EL, Kasali FM, Deyno S, Mtewa A, Nagendrappa PB, Tolo CU, Ogwang PE, Sesaazi D. Peter EL, et al. J Ethnopharmacol. 2019 Mar 1;231:311-324. doi: 10.1016/j.jep.2018.10.033. Epub 2018 Oct 30. J Ethnopharmacol. 2019. PMID: 30385422

4

Sweet potato for type 2 diabetes mellitus.

Ooi CP, Loke SC. Ooi CP, et al. Cochrane Database Syst Rev. 2012 Feb 15;(2):CD009128. doi: 10.1002/14651858.CD009128.pub2. Cochrane Database Syst Rev. 2012. PMID: 22336861 Updated. Review.

5

Sweet potato for type 2 diabetes mellitus.

Ooi CP, Loke SC. Ooi CP, et al. Cochrane Database Syst Rev. 2013 Sep 3;2013(9):CD009128. doi: 10.1002/14651858.CD009128.pub3. Cochrane Database Syst Rev. 2013. PMID: 24000051 Free PMC article. Review.

6

Safety and efficacy of Momordica charantia Linnaeus in pre-diabetes and type 2 diabetes mellitus patients: a systematic review and meta-analysis protocol.

Peter EL, Deyno S, Mtewa A, Kasali FM, Nagendrappa PB, Sesaazi D, Tolo CU, Ogwang PE. Peter EL, et al. Syst Rev. 2018 Nov 15;7(1):192. doi: 10.1186/s13643-018-0847-x. Syst Rev. 2018. PMID: 30442186 Free PMC article.

7

Systematic review and meta-analysis protocol for efficacy and safety of Momordica charantia L. on animal models of type 2 diabetes mellitus.

Peter EL, Mtewa AG, Nagendrappa PB, Kaligirwa A, Sesaazi CD. Peter EL, et al. Syst Rev. 2020 Jan 8;9(1):7. doi: 10.1186/s13643-019-1265-4. Syst Rev. 2020. PMID: 31915054 Free PMC article.

8

Colesevelam for type 2 diabetes mellitus.

Ooi CP, Loke SC. Ooi CP, et al. Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD009361. doi: 10.1002/14651858.CD009361.pub2. Cochrane Database Syst Rev. 2012. PMID: 23235674 Free PMC article. Review.

9

Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.

Hemmingsen B, Schroll JB, Lund SS, Wetterslev J, Gluud C, Vaag A, Sonne DP, Lundstrøm LH, Almdal T. Hemmingsen B, et al. Cochrane Database Syst Rev. 2013 Apr 30;(4):CD009008. doi: 10.1002/14651858.CD009008.pub2. Cochrane Database Syst Rev. 2013. PMID: 23633364 Updated. Review.

10

The effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus needs further studies.

Dans AM, Villarruz MV, Jimeno CA, Javelosa MA, Chua J, Bautista R, Velez GG. Dans AM, et al. J Clin Epidemiol. 2007 Jun;60(6):554-9. doi: 10.1016/j.jclinepi.2006.07.009. Epub 2006 Nov 13. J Clin Epidemiol. 2007. PMID: 17493509 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

122 results

Results by year